4//SEC Filing
LLOYD RONALD K. 4
Accession 0001104659-20-114635
CIK 0001708527other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 9:57 PM ET
Size
7.3 KB
Accession
0001104659-20-114635
Insider Transaction Report
Form 4
LLOYD RONALD K.
DirectorPresident and CEO
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-10-13−111,788→ 0 total→ Class A Common Stock (14,586 underlying) - Conversion
Class A Common Stock
2020-10-13+14,586→ 14,586 total
Footnotes (1)
- [F1]Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering. In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering).
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001644078
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 9:57 PM ET
- Size
- 7.3 KB